Fireblocks, a global leader in digital assets, has facilitated over $10 trillion in secure transfers. Silo Pharma, a biopharmaceutical and cryptocurrency treasury company, is partnering with Fireblocks to enhance its crypto treasury management platform. The collaboration aims to build institutional-grade infrastructure for buying, staking, and managing digital assets at scale. Silo Pharma focuses on developing treatments for stress-induced psychiatric disorders, chronic pain, and CNS diseases, with innovative programs like SPC-15 for PTSD and SP-26 for fibromyalgia. The company conducts research in collaboration with universities and laboratories.

Read more at GlobeNewswire: Silo Pharma Updates Strategic Agreement with Fireblocks to